Efficacy and Tolerability of Suprep With and Without Simethicone for Routine Colonoscopy for Colorectal Cancer Screening

Withdrawn before enrolling · Not applicable · Has a placebo group

Conditions studied: Colorectal Cancer

In brief

The purpose of this study is to investigate Suprep bowel preparation, with and without the anti-gas medication simethicone, in terms of efficacy and patient tolerability in the preparation of patients undergoing routine colonoscopy for colorectal cancer screening.

Key facts

Study ID

NCT02523911

Run by

MercyOne Des Moines Medical Center

People needed

0

Starts

2016-03-01

Expected to finish

2017-12-01

Last updated by the study team

2020-02-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age greater than 18 years
• Outpatients who require elective colonoscopy for colorectal cancer screening at Iowa Endoscopy Center and at University of Florida - Jacksonville

You may not qualify if…

• Allergy or hypersensitivity to any constituent of the lavage solution or to simethicone
• Presence of any contraindication to colonoscopy (i.e. uncontrolled congestive heart failure, New York Heart Association classification III-IV, history of myocardial infarction within 6 months, coagulopathy)
• Massive ascites
• Renal insufficiency
• Pregnancy
• History of colonic surgery
• History of anti-flatulence or laxative agent within one week
• Refusal/inability to give consent
• Patients undergoing colonoscopy for reasons other than colorectal cancer screening
• Mentally disabled
• Non-English-speaking patients

Where it is running

• UF Health Jacksonville — Jacksonville, Florida, United States
• Iowa Endoscopy Center — Clive, Iowa, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.